Shirel Dorman-Ilan

Shirel Dorman-Ilan

Auto-generated profile, based on publicly available information

Shirel Dorman-Ilan

Sheba Medical Center

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 March 2022 in medRxiv
Verified
Preprint
Open access
PDF file
Nimrod Hertz-PalmorNimrod Hertz-Palmor
Nimrod Hertz-Palmor
SRShachar Ruppin
Shachar Ruppin
NMNoam Matalon
Noam Matalon
MMMariela Mosheva
Mariela Mosheva
SDShirel Dorman-Ilan
Shirel Dorman-Ilan
IPItai M. Pessach
Itai M. Pessach
Background: The COVID-19 pandemic is an ongoing global crisis, with a multitude of factors that affect mental health worldwide. Here, we explore potential predictors for the emergence and maintenance of depression, anxiety, and posttraumatic stress symptoms (PTSS) in the general population in Israel. Methods: Across the span of 16 months, 2,478 people completed a repeated self-report survey which inquired psychiatric symptoms and pandemic related stress factors (PRSF). PRSF were divided into four clusters of environmental stressors: financial, health-related, fatigue and sense of protection by authorities. We applied mixed-effects linear models to assess how each stressor contributes to depression, anxiety and PTSS at each time point, alongside a longitudinal exploration among participants who completed at least two consecutive surveys ( n =400). Results: Fatigue was the strongest predictor for depression, anxiety and PTSS at all time points ( standardized β between 0.28-0.60, p <.0001), and predicted deterioration overtime ( β between 0.22-0.36, p <.0001). Financial concerns associated with depression and anxiety at all time points ( β between 0.13- 0.26, p <.01), and with their deterioration overtime ( β between 0.16-0.18, p <.0001), while health related concerns were uniquely associated with anxiety and PTSS at all time points ( β between 0.14-0.29, p <.01) and their deterioration ( β between 0.11-0.16, p <.001), but not with depression. Improvement in sense of protection overtime associated with decrease in depression and anxiety ( β between −0.09 to −0.16, p <.01). Conclusions: Our findings accentuate the multitude of risk factors for psychiatric morbidity during COVID-19, and the dynamics in their association with different aspects of psychopathology at various time points.